Publications
- Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Risk factors of Asymptomatic (Smoldering) Multiple Myeloma2014 | Faculty of Medicine in Hradec Králové
- Importance of FLC determination in patients with MGUS and in complete remission of multiple myeloma2012 | Faculty of Medicine in Hradec Králové
- Monoclonal immunoglobulins - occurrence, importance and possibilities of their identitication2012 | Faculty of Medicine in Hradec Králové
- The role of procalcitonin in the differential diagnosis of fever in patients with multiple myeloma2011 | Faculty of Medicine in Hradec Králové
- Hyperviscosity syndrome in patients with multiple myeloma2011 | Faculty of Medicine in Hradec Králové
- Lenalidomide in the treatment of multiple myeloma +12009 | Faculty of Medicine in Hradec Králové
- Lenalidomide in the treatment of multiple myeloma2009 | First Faculty of Medicine
Loading network view...